Clinical Trial for Immunostimulating effect of Physta(R)/Eurycoma Longifolia Extract - A Randomized Controlled Trial.
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000011753
- Lead Sponsor
- ORTHOMEDICO, Inc.
- Brief Summary
George A, Suzuki N, Abas AB, Mohri K, Utsuyama M, Hirokawa K, Takara T. Immunomodulation in Middle-Aged Humans Via the Ingestion of Physta Standardized Root Water Extract of Eurycoma longifolia Jack-A Randomized, Double-Blind, Placebo-Controlled, Parallel Study. Phytother Res. 2016; 30(4): 627-35.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Not provided
a) Persons who have previous medical history of heart failure and cardiacinfarction b) Patients being treated for arterial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, dyslipidemia, hypertension, and other chronic disease c) Persons who takes medicines, herbal medicines, and dietary supplements within 30 days d) Persons who has allergy e) Pregnant women, lactating women, or women who want to get pregnant during the trial period f) Pollinosis patients g) Smokers h) Persons who enrolled in the other clinical trials within last 3 months before the agreement for the participation to the trial i) Persons who investigator judge not suitable to participate in the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method